Home
About us
Company
Strategy
Organization
Team
Companies
Partners
News
Contacts
©2021 - TechWald Holding S.p.A.
TWH@TechWald.com
VAT 11712520011
Privacy Policy
Cookie Policy
Credits
News
Press release
/ Sep 9, 2019
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System in the Treatment of Pulmonary Arterial Hypertension (PAH)…
Read More
Press release
/ Jun 11, 2019
New System Could Hold Promise for Patients Suffering from Pulmonary Arterial Hypertension…
Read More
Press release
/ May 27, 2019
Ultrasound-Based Denervation Gains Traction in PAH – Small study offers favorable hemodynamic, exercise tolerance numbers…
Read More
Press release
/ May 23, 2019
SoniVie Presents Clinical Trial Data Supporting the Safety and Efficacy of the TIVUS™ System in the Treatment of Pulmonary Arterial Hypertension…
Read More
Press release
/ May 23, 2019
SoniVie Appoints Charles Carignan, MD, Chief Executive Officer and Announces Upcoming Presentation of TIVUS (TM) Clinical Trial Data at EuroPCR 2019…
Read More
Press release
/ May 23, 2019
Amid obesity, Israeli startup develops Endozip device to stitch up stomach bulge Caesarea-based Nitinotes says it is working on a safe, automated, and minimally invasive suturing solution, tailor-made to help with weight reduction…
Read More
Press release
/ Nov 30, 2018
TechWald Holding SpA (Turin, Italy and Tel-Aviv, Israel) has entered into a strategic global partnership with Nocturnal Product Development, LLC (Research Triangle Park, NC) to evaluate, fund, and develop innovative medical technologies…
Read More
Posts navigation
1
2
Home
About us
Company
Strategy
Organization
Team
Companies
Partners
News
Contacts
